Original Article
Outcomes of patients with esophageal cancer after allogeneic hematopoietic stem cell transplantation
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2705-2712
.
(28 December 2022)
Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2713-2720
.
(28 December 2022)
Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using 18F-FDG PET-CT imaging: a prospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2721-2735
.
(28 December 2022)
The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2736-2748
.
(28 December 2022)
Application value of continuous seromuscular layer sutures in the reinforcement of esophagojejunostomy in total gastrectomy for gastric cancer: a retrospective comparative cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2749-2757
.
(28 December 2022)
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2758-2768
.
(28 December 2022)
Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2769-2778
.
(28 December 2022)
Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2779-2788
.
(28 December 2022)
Obstructive sleep apnea and the incidence and mortality of gastrointestinal cancers: a systematic review and meta-analysis of 5,120,837 participants
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2789-2798
.
(28 December 2022)
Decitabine enhances the tumoricidal potential of TRAIL via the epigenetic regulation of death receptor 4 in gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2799-2808
.
(28 December 2022)
Long non-coding RNA CNALPTC1 promotes gastric cancer progression by regulating the miR-6788-5p/PAK1 pathway
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2809-2822
.
(28 December 2022)
Knockdown of carboxypeptidase A4 (CPA4) inhibits gastric cancer cell progression via cell cycle arrest and apoptosis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2823-2831
.
(28 December 2022)
LncRNA NORAD mediates KMT2D expression by targeting miR-204-5p and affects the growth of gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2832-2844
.
(28 December 2022)
Prognostic value of nicotinamide adenine dinucleotide (NAD+) metabolic genes in patients with stomach adenocarcinoma based on bioinformatics analysis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2845-2862
.
(28 December 2022)
Comparison of efficacy and safety between endoscopic and laparoscopic resections in the treatment of gastric stromal tumors: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2863-2873
.
(28 December 2022)
Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2874-2884
.
(28 December 2022)
The hsa_circ_0007396-miR-767-3p-CHD4 axis is involved in the progression and carcinogenesis of gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2885-2902
.
(28 December 2022)
Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2903-2921
.
(28 December 2022)
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2922-2937
.
(28 December 2022)
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2938-2950
.
(28 December 2022)
Rectal tumor fragmentation as a response pattern following chemoradiation
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2951-2962
.
(28 December 2022)
Effects of sevoflurane and propofol on postoperative nausea and vomiting in patients with colorectal cancer placed under general anesthesia: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2963-2972
.
(28 December 2022)
Clinical study on risk factors related to postoperative recurrence or metastasis of rectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2973-2988
.
(28 December 2022)
PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6
Journal of Gastrointestinal Oncology
2022;
13
(6)
:2989-3008
.
(28 December 2022)
A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3009-3024
.
(28 December 2022)
Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3025-3037
.
(28 December 2022)
Identification of genes and cellular response factors related to immunotherapy response in mismatch repair-proficient colorectal cancer: a bioinformatics analysis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3038-3055
.
(28 December 2022)
Screening and identification of hub gene and differential gene and mutation sequence analysis of related genes in colorectal cancer based on bioinformatics analysis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3056-3066
.
(28 December 2022)
Expression and clinical significance of miR-17-5p in tumor tissues of patients with colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3067-3079
.
(28 December 2022)
The prognostic role of fasting plasma glucose levels on survival in advanced colorectal cancer patients with type II diabetes mellitus: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3080-3089
.
(28 December 2022)
Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3090-3099
.
(28 December 2022)
Plasminogen activator, urokinase enhances the migration, invasion, and proliferation of colorectal cancer cells by activating the Src/ERK pathway
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3100-3111
.
(28 December 2022)
The miRNA125a-5p and miRNA125b-1-5p cluster induces cell invasion by down-regulating DDB2-reduced epithelial-to-mesenchymal transition (EMT) in colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3112-3122
.
(28 December 2022)
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3123-3134
.
(28 December 2022)
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3135-3153
.
(28 December 2022)
Comprehensive analysis of an autophagy-related prognostic model for predicting survival based on TCGA and ICGC database in hepatocellular carcinoma patients
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3154-3168
.
(28 December 2022)
Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3169-3182
.
(28 December 2022)
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3183-3192
.
(28 December 2022)
Identification of characteristic markers correlated with Th2 cell infiltration and metabolism molecular subtype in pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3193-3206
.
(28 December 2022)
Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3207-3215
.
(28 December 2022)
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3216-3226
.
(28 December 2022)
Adjuvant treatment for the elderly patient with resected gallbladder cancer: a SEER-Medicare analysis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3227-3239
.
(28 December 2022)
A descriptive analysis of the characteristics, treatment response and prognosis of hepatic dominant solid tumors undergoing selective internal radiation therapy (SIRT)
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3240-3253
.
(28 December 2022)
Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3254-3262
.
(28 December 2022)
MicroRNA-543 controls pancreatic cancer development by LINC00847-microRNA-543-STK31 axis
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3263-3277
.
(28 December 2022)
Downregulation of LINC01426 inhibits the proliferation and migration of human pancreatic cancer cells in vivo and in vitro
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3278-3289
.
(28 December 2022)
Development and validation of an XGBoost model to predict 5-year survival in elderly patients with intrahepatic cholangiocarcinoma after surgery: a SEER-based study
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3290-3299
.
(28 December 2022)
Study Protocol
Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3300-3313
.
(28 December 2022)
Case Report
Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3314-3320
.
(28 December 2022)
Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma—a case report
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3321-3328
.
(28 December 2022)
Concurrent Epstein Barr virus-associated smooth muscle tumor and myeloid sarcoma of the liver and acute myeloid leukemia in a patient post kidney transplant: a case report and review of the literature
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3329-3335
.
(28 December 2022)
Letter to the Editor
Is perioperative lymphocyte-to-monocyte ratio changes plus CA199 has high value in predicting the prognosis of patients with gastric cancer?
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3336-3337
.
(28 December 2022)
Meta-analysis and systematic review of the relationship between ulcerative colitis and colon cancer
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3338-3339
.
(28 December 2022)
Was ulcerative colitis one of the risk factors of colorectal cancer?
Journal of Gastrointestinal Oncology
2022;
13
(6)
:3340
.
(28 December 2022)
